Document Detail


Survey of practices employed by neurologists for the definition and management of secondary non-response to botulinum toxin in cervical dystonia.
MedLine Citation:
PMID:  23597436     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Secondary non-response (SNR) to botulinum toxin (BoNT) in cervical dystonia (CD) lacks a universal definition. We conducted a retrospective survey to develop a definition based on clinicians' practice. Fifty-seven neurologists completed a 17-item questionnaire. In defining SNR, insufficiently improved posture was considered to be more relevant (98% of physicians) than insufficiently improved pain (86%). The most frequently used diagnostic test for SNR was the frontalis test (68%); antibody testing was performed by only 13% of physicians. Three consecutive unsuccessful injection cycles were considered the most appropriate indicator of SNR (55% of physicians). Physicians reported that 5.9% (median) of patients treated in 2008 became secondary non-responders to BoNT-A. The most common strategy for SNR was optimization of physiotherapy, considered by 98% of the physicians. On the basis of our findings, SNR can be defined as insufficiently improved posture after ≥3 unsuccessful injection cycles in CD patients previously achieving satisfactory results.
Authors:
Joaquim J Ferreira; Roongroj Bhidayasiri; Carlo Colosimo; Maria Jose Marti; Benjamin Zakine; Pascal Maisonobe
Related Documents :
12808696 - Hospitalization of criminal defendants for evaluation of competence to stand trial or f...
4650846 - Increasing frequency of gall bladder operations in the bristol clinical area.
7376026 - The surgical gastro-intestinal motility clinic: the history of oesophagology at groote ...
3306786 - Clinicians' appraisal of sonography.
25114936 - Identification and management of adverse effects of antipsychotics in a tertiary care t...
8441496 - Applying atls to the gulf war.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Functional neurology     Volume:  27     ISSN:  0393-5264     ISO Abbreviation:  Funct. Neurol.     Publication Date:    2012 Oct-Dec
Date Detail:
Created Date:  2013-04-19     Completed Date:  2013-06-18     Revised Date:  2014-01-09    
Medline Journal Info:
Nlm Unique ID:  8707746     Medline TA:  Funct Neurol     Country:  Italy    
Other Details:
Languages:  eng     Pagination:  225-30     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anti-Dyskinesia Agents / adverse effects*
Botulinum Toxins / adverse effects*
Female
Health Surveys
Humans
Male
Pain Measurement
Physicians / psychology*
Questionnaires
Retrospective Studies
Torticollis / diagnosis*,  drug therapy*
Chemical
Reg. No./Substance:
0/Anti-Dyskinesia Agents; EC 3.4.24.69/Botulinum Toxins
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Lack of maintenance of gait pattern as measured by instrumental methods suggests psychogenic gait.
Next Document:  Spatiotemporal and kinematic aspects of obstacle avoidance in subjects with Down syndrome.